[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid

C86H110N16O19 — CID 174236934

IUPAC[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid
SMILESCOc1cc(=O)n(C)cc1-c1ccc2nc(N3CCC(CN4C[C@@H](C)N(C(=O)c5ccc(OC)c(N6CCC(=O)NC6=O)c5)C[C@@H]4C)CC3)nc(C(CO)(CC3CC3)c3ccc(C(Cc4ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCOCCOCCN5C(=O)C=CC5=O)C(C)C)cc4)(CN(C)C(=O)O)N(C)C(=O)O)cc3)c2c1
InChIInChI=1S/C86H110N16O19/c1-52(2)75(92-71(105)31-37-120-39-40-121-38-36-101-72(106)26-27-73(101)107)78(110)90-66(11-10-32-88-80(87)112)77(109)89-62-22-14-56(15-23-62)45-86(97(7)84(116)117,50-96(6)83(114)115)61-20-18-60(19-21-61)85(51-103,44-55-12-13-55)76-63-41-58(64-49-95(5)74(108)43-69(64)119-9)16-24-65(63)91-81(94-76)98-33-28-57(29-34-98)48-99-46-54(4)102(47-53(99)3)79(111)59-17-25-68(118-8)67(42-59)100-35-30-70(104)93-82(100)113/h14-27,41-43,49,52-55,57,66,75,103H,10-13,28-40,44-48,50-51H2,1-9H3,(H,89,109)(H,90,110)(H,92,105)(H,114,115)(H,116,117)(H3,87,88,112)(H,93,104,113)/t53-,54+,66-,75-,85?,86?/m0/s1
InChIKeyLPTTWMLETXFNSF-DIAKQCINSA-N
MW1671.92 g/mol
LogP6.01
Rot. Bonds38

About [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid

[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid (PubChem CID 174236934) has the molecular formula C86H110N16O19 and a molecular weight of 1671.92 g/mol. Its IUPAC name is [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid.

Molecular Properties

Compound Name[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid
PubChem CID174236934
Molecular FormulaC86H110N16O19
Molecular Weight1671.92 g/mol
Exact Mass1670.81
IUPAC Name[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid
SMILESCOc1cc(=O)n(C)cc1-c1ccc2nc(N3CCC(CN4C[C@@H](C)N(C(=O)c5ccc(OC)c(N6CCC(=O)NC6=O)c5)C[C@@H]4C)CC3)nc(C(CO)(CC3CC3)c3ccc(C(Cc4ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCOCCOCCN5C(=O)C=CC5=O)C(C)C)cc4)(CN(C)C(=O)O)N(C)C(=O)O)cc3)c2c1
InChIInChI=1S/C86H110N16O19/c1-52(2)75(92-71(105)31-37-120-39-40-121-38-36-101-72(106)26-27-73(101)107)78(110)90-66(11-10-32-88-80(87)112)77(109)89-62-22-14-56(15-23-62)45-86(97(7)84(116)117,50-96(6)83(114)115)61-20-18-60(19-21-61)85(51-103,44-55-12-13-55)76-63-41-58(64-49-95(5)74(108)43-69(64)119-9)16-24-65(63)91-81(94-76)98-33-28-57(29-34-98)48-99-46-54(4)102(47-53(99)3)79(111)59-17-25-68(118-8)67(42-59)100-35-30-70(104)93-82(100)113/h14-27,41-43,49,52-55,57,66,75,103H,10-13,28-40,44-48,50-51H2,1-9H3,(H,89,109)(H,90,110)(H,92,105)(H,114,115)(H,116,117)(H3,87,88,112)(H,93,104,113)/t53-,54+,66-,75-,85?,86?/m0/s1
InChIKeyLPTTWMLETXFNSF-DIAKQCINSA-N
XLogP6.01
TPSA442.01 Ų
H-Bond Donors9
H-Bond Acceptors22
Rotatable Bonds38
Heavy Atoms121
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001671.92
LogP ≤ 56.01
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid?
The IUPAC name of [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid (CID 174236934) is [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid.
What is the SMILES notation for [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid?
The canonical SMILES for [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid is COc1cc(=O)n(C)cc1-c1ccc2nc(N3CCC(CN4C[C@@H](C)N(C(=O)c5ccc(OC)c(N6CCC(=O)NC6=O)c5)C[C@@H]4C)CC3)nc(C(CO)(CC3CC3)c3ccc(C(Cc4ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCOCCOCCN5C(=O)C=CC5=O)C(C)C)cc4)(CN(C)C(=O)O)N(C)C(=O)O)cc3)c2c1.
What is the InChIKey of [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid?
The InChIKey is LPTTWMLETXFNSF-DIAKQCINSA-N. The full InChI is InChI=1S/C86H110N16O19/c1-52(2)75(92-71(105)31-37-120-39-40-121-38-36-101-72(106)26-27-73(101)107)78(110)90-66(11-10-32-88-80(87)112)77(109)89-62-22-14-56(15-23-62)45-86(97(7)84(116)117,50-96(6)83(114)115)61-20-18-60(19-21-61)85(51-103,44-55-12-13-55)76-63-41-58(64-49-95(5)74(108)43-69(64)119-9)16-24-65(63)91-81(94-76)98-33-28-57(29-34-98)48-99-46-54(4)102(47-53(99)3)79(111)59-17-25-68(118-8)67(42-59)100-35-30-70(104)93-82(100)113/h14-27,41-43,49,52-55,57,66,75,103H,10-13,28-40,44-48,50-51H2,1-9H3,(H,89,109)(H,90,110)(H,92,105)(H,114,115)(H,116,117)(H3,87,88,112)(H,93,104,113)/t53-,54+,66-,75-,85?,86?/m0/s1.
What are the key properties of [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid?
[1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid has a molecular weight of 1671.92 g/mol, XLogP of 6.01, 38 rotatable bonds, 9 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]-3-[carboxy(methyl)amino]-2-[4-[1-cyclopropyl-2-[2-[4-[[(2S,5R)-4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]-2,5-dimethylpiperazin-1-yl]methyl]piperidin-1-yl]-6-(4-methoxy-1-methyl-6-oxo-3-pyridinyl)quinazolin-4-yl]-3-hydroxypropan-2-yl]phenyl]propan-2-yl]-methylcarbamic acid is sourced from PubChem (CID 174236934), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).